europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EFIB 2022 Start-up Village: applications are open!

15/06/2022
PRESS RELEASE
EuropaBio and local hosts Lithuanian Biotechnology Association, Innovation Agency Lithuania and Go Vilnius are inviting start-ups to submit their application for participation in the EFIB 2022 Start-up Village. Founders of start ups that are active in industrial biotechnology and bioeconomy a with a business focus on new bio-based technologies will have a chance to gain a strong visibility to more than 500 EFIB attendees, while having a valuable opportunity for networking and exchange with industry experts, CEOs, policy makers as well as various stakeholders during two days of the Conference.

Participation in the Start-up Village includes:
-Free spot in the Start-up Village and free access to the 1:1 conference partnering
-Free admission for one company representative to EFIB and reduced fee for other company representatives

Start up hour at EFIB
Selected start up village participants will also have a pitching slot during our dedicated “Start-up Hour” on October 26, 2022

How to apply?
We invite founders to apply for the Start-up Village if they are active in industrial biotechnology and bioeconomy with a business focus on new bio-based technologies, services, or industrial application for the following areas/sectors:

-Food, feed and nutrition
-Bioprocesses and Technologies
-Sustainable Biomaterials

Your application should include a pitch deck (PDF with a max of 25 pages) with the following information:
-Business idea and state of science/technology & development phase of the bio-based solution
-Targeted application area(s)/sector & market volume
-Outlook of the next milestones(3+ years)
-Overview of funding team and management

If you are interested, please submit your application by July 15 2022.

EFIB 2022 Start-up Village: applications are open!


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

30/05/2023

Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action


Read more
24/05/2023

SwedenBIO joins EuropaBio: helping innovative companies succeed!


Read more
24/05/2023

Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids


Read more
23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more

Important links

  • Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action
  • SwedenBIO joins EuropaBio: helping innovative companies succeed!

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies